#Marpai Inc #AXA #JGB Capital

Marpai Inc. Restructures Debt for Enhanced Growth

Marpai, Inc. has recently announced the successful completion of debt restructuring agreements with its primary lenders, JGB Capital and AXA S.A. This strategic move is aimed at significantly enhancing the company's liquidity and aligning its debt service commitments with its operational cash flows. By reducing its near-term debt service payments by a substantial $26.4 million, Marpai aims to unlock financial potential which will be redirected towards growth initiatives and operational stability.

Key Highlights of the Restructuring

In May and July 2026, Marpai entered into agreements with JGB Capital and AXA, respectively. Notably, the deal with JGB extends the maturity of the Debentures issued via the JGB Purchase Agreement by an additional year to April 15, 2028. This amendment also revised the original amortization schedule, providing updated timelines for repayment that ensure more manageable cash flow alignment.

Simultaneously, the agreement with AXA restructures Marpai's existing repayment timeline, changing the previous schedule to incorporate new minimum annual payments while also extending the debt maturity to December 31, 2029. These changes are designed to alleviate immediate liquidity pressures and bolster financial flexibility for the company, which operates in the highly competitive field of healthcare technology and Third-Party Administration (TPA) services.

Focus on Operational Resilience

The restructuring will ease the financial burdens on Marpai in the short term, which is particularly crucial as the company pursues its growth strategies. CEO Damien Lamendola expressed gratitude to JGB and AXA for their cooperation throughout this process, stating that **